NHS watchdog refuses to pay for lung cancer drug "Crizotinib" that"s twice as effective as chemotherapy

NHS watchdog refuses to pay for lung cancer drug that is twice as effective as chemo and could benefit 1,000 patients a yearNew drug halts advance of non-small cell lung cancer for eight monthsCrizotinib costs 4,000 a month and could benefit 1,000 patients a yearNHS watchdog deems it too expensive due to lack of evidence of benefits By Jenny Hope PUBLISHED: 00:07 GMT, 27 March 2013 | UPDATED: 10:06 GMT, 27 March 2013 Access denied: Crizotinib could benefit 1,000 patients a year but is deemed to lack evidence of benefits says NHS A new drug that combats a specific type of lung cancer is too expensive for the NHS, says the rationing watchdog.

NHS watchdog refuses to pay for lung cancer drug that is twice as effective as chemo and could benefit 1,000 patients a year

NHS watchdog refuses to pay for lung cancer drug that is twice as effective as chemo and could benefit 1,000 patients a yearNew drug halts advance of non-small cell lung cancer for eight monthsCrizotinib costs 4,000 a month and could benefit 1,000 patients a yearNHS watchdog deems it too expensive due to lack of evidence of benefits By Jenny Hope PUBLISHED: 00:07 GMT, 27 March 2013 | UPDATED: 07:55 GMT, 27 March 2013 Access denied: Crizotinib could benefit 1,000 patients a year but is deemed to lack evidence of benefits says NHS A new drug that combats a specific type of lung cancer is too expensive for the NHS, says the rationing watchdog.

Georgetown University Medical Centre: Scientists discover "greedy gene that makes you eat more even when you are full

‘Greedy gene’ that makes you eat more even when you are full is uncovered by scientistsCould lead to treatments for obesity | UPDATED: 19:28 GMT, 18 March 2012 The secret to staying slim may be all in your genes.